Michel Vounatsos
Director/Board Member bei REVVITY, INC.
Vermögen: 15 Mio $ am 31.03.2024
Profil
Michel Vounatsos ist Mitglied des Vorstands von PerkinElmer, Inc. (Vereinigte Staaten), LInstitut de RYthmologie et Modlisation Cardiaque und n-Lorem Foundation sowie Chief Executive Officer & Director bei Biogen, Inc. In seiner früheren Laufbahn hatte er die Position des President-Primary Care & Customer Business Line bei Merck & Co, Inc. inne. Herr Vounatsos erhielt einen MBA von der Cole des Hautes tudes Commerciales de Paris.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOGEN INC.
0,05% | 28.04.2023 | 67 262 ( 0,05% ) | 15 Mio $ | 31.03.2024 |
REVVITY, INC.
0,01% | 15.05.2023 | 6 486 ( 0,01% ) | 681 030 $ | 31.03.2024 |
ZAI LAB LTD.
0,02% | 30.06.2023 | 183 320 ( 0,02% ) | 302 159 $ | 31.03.2024 |
Aktive Positionen von Michel Vounatsos
| Unternehmen | Position | Beginn |
|---|---|---|
| REVVITY, INC. | Director/Board Member | 01.03.2020 |
| ZAI LAB LIMITED | Director/Board Member | 07.01.2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Chief Executive Officer | 06.01.2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Chief Executive Officer | - |
| L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
| n-Lorem Foundation | Director/Board Member | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Board Member | - |
Ehemalige bekannte Positionen von Michel Vounatsos
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Chief Executive Officer | 14.11.2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.04.2016 |
Ausbildung von Michel Vounatsos
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
| L’Institut de RYthmologie et Modélisation Cardiaque | |
| n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
